emoxypine succinate has been researched along with Chronic Pancreatitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akhmedov, VA; Budylgin, AV; Dolgikh, VT | 1 |
| Pimenov, LT; Samarin, AG | 1 |
2 trial(s) available for emoxypine succinate and Chronic Pancreatitis
| Article | Year |
|---|---|
[The matrix metalloproteinase 9 (MMP-9) and TIMP-1 activities in patients with chronic and recurrent pancreatitis].
Topics: Adult; Antioxidants; Drug Therapy, Combination; Female; Humans; Interleukin-1beta; Male; Matrix Metalloproteinase 9; Middle Aged; Pancreatitis, Chronic; Picolines; Secondary Prevention; Tissue Inhibitor of Metalloproteinase-1; Treatment Outcome; Tumor Necrosis Factor-alpha | 2010 |
[Chronic pancreatitis: quality of a life and possibilities of pharmacological correction by ethylmethylhydroxypyridine succinate].
Topics: Adult; Amylases; Antioxidants; Drug Therapy, Combination; Female; Humans; Lipase; Lipids; Male; Middle Aged; Pain Measurement; Pancreatitis, Chronic; Picolines; Psychological Tests; Psychotropic Drugs; Quality of Life; Treatment Outcome | 2010 |